Terumo Introduces New Proprietary Oxygenator to Market.Tokyo, Japan, Sept 13, 2005 - (JCNN JCNN Japan Corporate News Network ) - Terumo announced on September 12 that it has begun marketing the CAPIOX RX15, a new model in its proprietary oxygenator oxygenatoran apparatus by which oxygen is introduced into the blood during circulation outside the body, as during open-heart surgery. See also extracorporeal circulatory support unit. series, to medical institutions across Japan. The new product features a smaller priming volume (135ml) while improving its gas exchange performance. Offered at an NHI NHI abbr. National Health Insurance reimbursement price of 208,000 yen ($1,890), the new oxygenerator is suitable for use for a wide range of patients from infants to adults. Japan has about 40,000 cardiac surgeries a year. Terumo is aiming for sales of 400 million yen ($3.6 mil) in fiscal 2005. The company also plans to market the CAPIOX RX15 overseas, first in Asia and then in Europe and the US. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion